EP2176198B8 - Improved incapacitant spray - Google Patents
Improved incapacitant sprayInfo
- Publication number
- EP2176198B8 EP2176198B8 EP08776178A EP08776178A EP2176198B8 EP 2176198 B8 EP2176198 B8 EP 2176198B8 EP 08776178 A EP08776178 A EP 08776178A EP 08776178 A EP08776178 A EP 08776178A EP 2176198 B8 EP2176198 B8 EP 2176198B8
- Authority
- EP
- European Patent Office
- Prior art keywords
- incapacitant
- mixture
- per cent
- proportion
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007921 spray Substances 0.000 title claims description 18
- 239000000203 mixture Substances 0.000 claims abstract description 90
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- RGOVYLWUIBMPGK-UHFFFAOYSA-N nonivamide Chemical compound CCCCCCCCC(=O)NCC1=CC=C(O)C(OC)=C1 RGOVYLWUIBMPGK-UHFFFAOYSA-N 0.000 claims abstract description 28
- 201000004569 Blindness Diseases 0.000 claims abstract description 10
- 238000009835 boiling Methods 0.000 claims abstract description 6
- 241001465754 Metazoa Species 0.000 claims abstract description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical group CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 40
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 239000003380 propellant Substances 0.000 claims description 10
- 230000007794 irritation Effects 0.000 claims description 9
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 7
- 210000003097 mucus Anatomy 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 4
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims description 4
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 239000001273 butane Substances 0.000 claims description 2
- 239000001569 carbon dioxide Substances 0.000 claims description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 2
- 125000003827 glycol group Chemical group 0.000 claims description 2
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 claims description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 2
- 239000001294 propane Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 description 8
- 210000004379 membrane Anatomy 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 4
- 150000002334 glycols Chemical class 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 238000012864 cross contamination Methods 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 231100001032 irritation of the eye Toxicity 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 230000009295 sperm incapacitation Effects 0.000 description 2
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 239000005643 Pelargonic acid Substances 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000000981 bystander Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C06—EXPLOSIVES; MATCHES
- C06D—MEANS FOR GENERATING SMOKE OR MIST; GAS-ATTACK COMPOSITIONS; GENERATION OF GAS FOR BLASTING OR PROPULSION (CHEMICAL PART)
- C06D7/00—Compositions for gas-attacks
Definitions
- This invention relates to incapacitants, and in particular to incapacitant sprays used in law enforcement.
- Incapacitants containing pelargonyl vanillylamide (PAVA) as the primary incapacitant are known from GB2337806. Such incapacitants have been developed using carriers comprising mixtures of alcohol and water to solubilise the PAVA. These incapacitants function by inducing temporary blindness when the mixture enters the eyes without causing injury to the skin or mucous membranes of an individual. Whilst some tears may be produced as a side effect of the incapacitant entering the eyes, it is not the production of tears which causes temporary blindness. Blindness results from intense pain in the eyes which causes the eyelids to close involuntarily rendering the person blind until such time as the effect of the incapacitant wears off.
- PAVA pelargonyl vanillylamide
- incapacitant mixtures are susceptible to freezing at temperatures below 2 0 C. Incapacitant sprays using this mixture are therefore of limited use in cold weather or in countries with a cold climate.
- the invention provides an incapacitant mixture comprising PAVA and a carrier, wherein the mixture induces temporary blindness and/or irritation in the mucus membranes in a human or animal, wherein the carrier is miscible with water and has a boiling point greater than that of water, and wherein PAVA is the primary incapacitant in the mixture, the proportion of PAVA in the mixture being 0.65 per cent or less.
- PAVA refers to pelargonic acid vannillylamide classified under CAS No. 2444-46-4.
- the proportion of PAVA in the mixture is 0.65 per cent or less by weight. More preferably, the proportion of PAVA is between 0.3 and 0.65 per cent by weight. Still more preferably, the proportion of PAVA is between 0.3 and 0.6 per cent by weight.
- the carrier is a glycol or glycerine.
- the proportion of the glycol or glycerine in the mixture is 50 per cent or more by weight. More preferably the proportion of the glycol or glycerine in the mixture is 60 per cent or more by weight. Still more preferably the proportion of glycol or glycerine in the mixture is 72 per cent by weight.
- Suitable glycols include any edible glycols from the glycol family, for example ethylene glycol or propylene glycol.
- the carrier is propylene glycol.
- the proportion of propylene glycol in the mixture is 50 per cent or more by weight. More preferably the proportion of propylene glycol in the mixture is 60 per cent or more by weight. More preferably the proportion of propylene glycol is between 65 and 90 per cent. Still more preferably, the proportion of propylene glycol is between 65 and 80 per cent by weight. Still more preferably, the proportion of propylene glycol is 72 per cent by weight.
- the mixture further comprises water.
- the proportion of water in the mixture 30 per cent or less by weight. More preferably, the proportion of water is between 20 and 30 per cent by weight. Still more preferably, the proportion of water in the mixture is 25 per cent by weight.
- the mixture further comprises an alcohol. Any suitable alcohol may be used.
- the alcohol is selected from the group comprising ethanol, propanol and isopropanol.
- the proportion of alcohol is 25 per cent or less by weight. More preferably, the proportion of alcohol is between 1.0 and 3.5 per cent by weight. Still more preferably, the proportion of alcohol is between 1.0 and 3.0 per cent by weight. Still more preferably the proportion of alcohol is 2.7 per cent by weight.
- the mixture is capable of inducing temporary blindness and/or irritation in the mucus membranes in a human, and more preferably the mixture is capable of inducing blindness and/or irritation in the mucus membranes in a human for more than 5 minutes.
- the mixture is a liquid between the temperatures of -2O 0 C and +5O 0 C.
- the mixture may comprise a dye or a marker or a UV dye or an Infrared dye or an optical brightener or a synthetic DNA tag.
- a synthetic DNA tag allows a sprayed individual to be linked to a particular batch of incapacitant spray.
- One embodiment of the invention provides an incapacitant spray comprising a means for storing and delivering an incapacitant mixture according to the invention.
- the storing means may be a can or a container.
- the delivery means may be an aerosol, the mixture of the invention comprising an aerosol propellant, such as nitrogen, carbon dioxide, 1,1,1,2-tetrafiuoro ethane (classified under CAS No, 811-97-2), dimethyl ether, butane, propane or oxygen.
- an aerosol propellant such as nitrogen, carbon dioxide, 1,1,1,2-tetrafiuoro ethane (classified under CAS No, 811-97-2), dimethyl ether, butane, propane or oxygen.
- the propellant is nitrogen.
- the delivery means may use pressurised air to expel the mixture of the invention form the storing means.
- the delivery means preferably includes a nozzle.
- an incapacitant mixture comprising 0.3 per cent PAVA; a carrier being 72 per cent propylene glycol; 25 per cent water and 2.7 per cent ethanol, all by weight, and propellant therefor, the said propellant being nitrogen.
- PAVA in any overspray remains in solution for a longer period of time and can be easily cleaned by simply wiping away and this lessens the effect of cross-contamination.
- Glycerine, and glycols for example propylene glycol
- Adding a proportion of an alcohol, for example ethanol, to a glycol or a glycol/water mixture lowers the surface tension of that mixture.
- a spray may be broken up into droplets.
- the size of the resulting droplets increases with the surface tension of the liquid.
- the incapacitant mixture of the invention has a higher surface tension than known incapacitant mixtures comprising with an alcohol and water based solvent.
- the incapacitant mixture of the invention will therefore will break up into larger droplet sizes. This is illustrated in the following examples: a) An incapacitant mixture having 0.3 per cent PAVA and a solvent comprising
- Droplet size distribution was measured from repeated short bursts of the mixture from a canister placed at distances of 1.0m, 2.0m and 3.0m from the measurement location. On average it was found that 79% of droplets resulting from the spray had a diameter of more than 10 micron.
- An incapacitant mixture according to the invention having 0.3 per cent
- PAVA 72.0 per cent propylene glycol, 25.0 per cent water and 2.7 per cent ethanol (all by weight), and nitrogen as a propellant was prepared.
- Droplet size distribution was measured from repeated short bursts of the mixture from a canister placed at distances of 1.0m, 2.0m and 3.0m from the measurement location. On average it was found that 99.18 per cent of droplets resulting from the spray had a diameter of more than 10 micron.
- Droplet sizes of more than 10 micron are unlikely to be inhaled into the human respiratory system in significant quantity. Inhalation of an incapacitant mixture causes a cough reflex response.
- the incapacitant mixture of the invention therefore provides a reduced cough reflex response compared to known incapacitant sprays.
- the mixture of the invention does not have any significant effect on the respiratory system, yet causes temporary blindness which is exceptionally effective in incapacitating humans. The person must be incapacitated during the journey to a police station for instance until he is locked in a cell. A person may be dosed repeatedly with the incapacitant of the invention, in order to keep him under control when the effects of one application begin to wear off.
- blindness results from intense pain in the eyes which causes the eyelids to close involuntarily rendering the person blind until such time as the effect of the incapacitant wears off.
- incapacitation resulting from irritation to the mucus membranes this is also a result of intense pain, felt in areas exposed skin covered with mucus membranes and immediately adjacent such areas of skin.
- the incapacitant is prevented from entering the eyes, the person may nevertheless be incapacitated by intense pain in and around the nose and mouth.
- the incapacitant mixture of the invention does not have any significant effect on the respiratory system. Whilst the mixture causes the tear ducts to swell and some tears to be produced, these are a side effect. Intense lachrymation is not the cause of incapacitation.
- An incapacitant mixture according to the invention having 0.3 per cent PAVA, 72.0 per cent propylene glycol, 25.0 per cent water and 2.7 per cent ethanol (all by weight), and nitrogen as a propellant was prepared.
- the incapacitant mixture had a surface tension similar to that of water.
- the incapacitant mixture was sprayed at a person in the region of the eyes.
- the incapacitant caused irritation of the eyes, thereby incapacitating the said person.
- the eyes watered in connection with the irritation caused by the incapacitant.
- An incapacitant mixture according to the invention having 0.3 per cent PAVA, 73.7 per cent propylene glycol, 25.0 per cent water and 1.0 per cent ethanol (all by weight), and nitrogen as a propellant was prepared.
- the incapacitant mixture was sprayed at a person in the region of the eyes.
- the incapacitant caused irritation of the eyes, thereby incapacitating the said person.
- the eyes watered in connection with the irritation caused by the incapacitant.
- the incapacitant mixture was also sprayed at a person wearing protective goggles, directly at the nose and mouth.
- the incapacitant caused irritation of the mucus membranes and intense pain in the mouth and nose, thereby incapacitating the said person. Even though the incapacitant is not sprayed into the eyes, the eyes may nevertheless water in connection with the irritation caused by the incapacitant.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Combustion & Propulsion (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0713011.5A GB0713011D0 (en) | 2007-07-05 | 2007-07-05 | Improved incapacitant spray |
PCT/GB2008/050543 WO2009004390A2 (en) | 2007-07-05 | 2008-07-07 | Improved incapacitant spray |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2176198A2 EP2176198A2 (en) | 2010-04-21 |
EP2176198B1 EP2176198B1 (en) | 2012-06-27 |
EP2176198B8 true EP2176198B8 (en) | 2012-08-01 |
Family
ID=38440415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08776178A Active EP2176198B8 (en) | 2007-07-05 | 2008-07-07 | Improved incapacitant spray |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2176198B8 (en) |
GB (2) | GB0713011D0 (en) |
WO (1) | WO2009004390A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018185523A1 (en) * | 2017-04-04 | 2018-10-11 | Ledins Toms | A defence spray and additive for water-cannons using iberverin as an ingredient |
US11320245B2 (en) * | 2018-11-13 | 2022-05-03 | David Daniel Rankin, Sr. | Non-lethal defensive fluid composition and pressurized delivery system |
US11662182B2 (en) | 2018-11-13 | 2023-05-30 | David Daniel Rankin, Sr. | Non-lethal defensive fluid composition and pressurized delivery system |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2000131A (en) * | 1932-03-01 | 1935-05-07 | Us Ordnance Engineers Inc | Disabling and incapacitating gas generating chemical |
US5217708A (en) * | 1992-02-05 | 1993-06-08 | Defense Technology Corporation Of America | Capsicum lachrymator |
DK0723948T3 (en) * | 1995-01-24 | 2003-06-23 | Defense Tech Corp America | Capsaicinoid-containing tear inducer |
GB9710636D0 (en) * | 1997-05-23 | 1997-07-16 | Bauer Eran N | Novel mixture |
WO2006055640A2 (en) * | 2004-11-19 | 2006-05-26 | Mace Security International, Inc. | Gel compositions |
AU2006216792B2 (en) * | 2005-02-22 | 2011-03-17 | Mace Trademark Ii, Inc. | Irritant-free gel compositions |
-
2007
- 2007-07-05 GB GBGB0713011.5A patent/GB0713011D0/en not_active Ceased
-
2008
- 2008-07-07 WO PCT/GB2008/050543 patent/WO2009004390A2/en active Application Filing
- 2008-07-07 GB GB0812372.1A patent/GB2453013B/en active Active
- 2008-07-07 EP EP08776178A patent/EP2176198B8/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2009004390A2 (en) | 2009-01-08 |
GB0812372D0 (en) | 2008-08-13 |
EP2176198A2 (en) | 2010-04-21 |
GB2453013B (en) | 2012-12-05 |
WO2009004390A3 (en) | 2009-02-26 |
EP2176198B1 (en) | 2012-06-27 |
GB0713011D0 (en) | 2007-08-15 |
GB2453013A (en) | 2009-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2176198B8 (en) | Improved incapacitant spray | |
US5314097A (en) | Long distance marking devices and related method | |
US5821450A (en) | Incapacitating composition and a device for its use | |
JP2960445B2 (en) | Aerosol composition | |
BR9810665A (en) | Process for killing flying insects, and spraying device. | |
US20190218156A1 (en) | Agonist/antagonist compositions and methods of use | |
US20100269762A1 (en) | Animal Deterrent Apparatus | |
US11920906B2 (en) | Non-lethal defensive fluid composition and pressurized delivery system | |
Waddington et al. | Police use of force, firearms and riot control | |
JP2001500397A (en) | How to extinguish tank fires | |
US7334745B2 (en) | Hazing a bird repellent solution | |
US6524286B1 (en) | Medical application system for animals | |
EP1317311A1 (en) | Fire engine trailer | |
CN108137988A (en) | Water proofing property plastic formulation | |
US5084097A (en) | Aerosol spray for self protection and identification of assailants | |
US5286979A (en) | Process for absorbing ultraviolet radiation using dispersed melanin | |
JP2729244B2 (en) | Aerosol products | |
US20180051963A1 (en) | Personal Safety Device | |
US6312701B1 (en) | Pelargonic acid vanillyamide containing tear gas | |
CN205279869U (en) | Police catcher | |
EP0723948B1 (en) | Capsaicinoid lachrymator | |
WO2012074922A1 (en) | Defense spray using isothiocyanate as an ingredient | |
RU2687429C1 (en) | Liquid composition of irritant action for self-protection means (versions) | |
RU2580741C2 (en) | Lacrimatory irritant action liquid composition for self-defence means (versions) | |
MXPA99010815A (en) | Pelargonic acid vanillylamide containing tear gas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20100205 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20100927 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: MORRIS, WAYNE |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 564117 Country of ref document: AT Kind code of ref document: T Effective date: 20120715 |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: BAUER, ERAN Owner name: BAUER, GERARD |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602008016811 Country of ref document: DE Effective date: 20120823 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120927 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20120627 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D Effective date: 20120627 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120928 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121027 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121029 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120731 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20121008 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20130328 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602008016811 Country of ref document: DE Effective date: 20130328 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120927 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20140331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120627 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20120707 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130731 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: RN Effective date: 20140422 Ref country code: FR Ref legal event code: D3 Effective date: 20140506 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20080707 |
|
PGRI | Patent reinstated in contracting state [announced from national office to epo] |
Ref country code: FR Effective date: 20140506 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20140731 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20140730 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20150731 Year of fee payment: 8 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 564117 Country of ref document: AT Kind code of ref document: T Effective date: 20150707 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150731 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150707 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: EUG |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160708 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20230727 Year of fee payment: 16 Ref country code: GB Payment date: 20230801 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230727 Year of fee payment: 16 Ref country code: DE Payment date: 20230731 Year of fee payment: 16 |